UK's Independent GLP-1 & Peptide Information Resource
About Slim Shots
The UK's leading educational source for Semaglutide, Tirzepatide, Retatrutide research and Melanotan 2 data — science-backed information delivered with clarity.
Our Mission
Slim Shots was established to make complex pharmaceutical data on metabolic compounds accessible to the UK public. We bridge the gap between clinical research and everyday understanding, ensuring everyone can access transparent, science-led information.
Today, we serve as a primary reference for Semaglutide, Tirzepatide, and Retatrutide — the triple agonist representing the next generation of weight management research. We also provide extensive documentation on Melanotan 2 (MT2) and its interactions with melanocortin receptors.
Our information is derived from verified pharmaceutical-grade sources and peer-reviewed clinical trials. That is the Slim Shots difference — educational integrity and transparent science.
Compound Profiles
Clinically studied mechanisms. Independent data analysis. Updated regularly with the latest UK research.
Semaglutide
A GLP-1 receptor agonist studied for appetite regulation. We analyse the trials behind Ozempic® and Wegovy® to provide clear clinical context.
Tirzepatide
A dual GLP-1/GIP receptor agonist. We explore the metabolic research powering Mounjaro® and how it differs from single-agonist compounds.
Retatrutide
The emerging triple agonist (GLP-1/GIP/Glucagon). We track the latest Phase II and III clinical findings for this cutting-edge research peptide.
Melanotan 2
A melanocortin receptor agonist. We detail the biochemical pathway of MT2 and its historical study in skin pigmentation research.
Scientific Leadership
Lukas Baumann M.Sc.
Founder & Chief Scientific Officer
With 17+ years of expertise in pharmaceutical development and therapeutics, Lukas leads the Slim Shots commitment to education and scientific rigour.
His background in GLP-1 agonists and analytical chemistry ensures that every compound profile — from Semaglutide to Retatrutide — is accurate, cited, and thorough.
Under his direction, Slim Shots has evolved into the UK's most trusted informational hub for injectable compounds and peptide science.
"Clarity in science leads to better decisions. At Slim Shots, we bridge the gap between complex research and public understanding."
Our Standards
Data Accuracy
We double-verify all data points using pharmaceutical-grade standards to ensure accuracy across all compound profiles.
Transparent Methodology
No marketing jargon. Clean, analytical reviews of Semaglutide, Tirzepatide, and Retatrutide based purely on the science.
Extensive Documentation
Access bibliographies, trial references, and pharmacology reports for every compound we analyse.
Expert Insights
Information distilled by researchers to help guide you through complex compound mechanisms and clinical interactions.
Up-To-Date Trials
We monitor global clinical trials and the UK pharmacopeia to ensure our data reflects the current state of research.
Confidential Access
Browsing our research data is completely confidential, with no tracking of your focus areas or personal inquiries.
Why Slim Shots for Scientific Knowledge?
The UK landscape for metabolic research is often clouded by commercially driven content. Slim Shots is different — we provide a pure data approach to Semaglutide, Tirzepatide, and Retatrutide with no agenda beyond accuracy.
- In-depth analysis of Ozempic®, Wegovy®, and Mounjaro® active ingredients
- Independent peer-review of all clinical trial references
- UK-based source of truth for peptide science
- Extensive Melanotan 2 pigmentation research data
- Established transparency in the UK since 2019
Supporting UK Metabolic Health Knowledge
Slim Shots is dedicated to cataloguing the UK's most studied metabolic compounds — including Semaglutide, Tirzepatide, and the experimental Retatrutide. These GLP-1 based discoveries have redefined the medical approach to weight management and endocrine health.
Our data on Semaglutide tracks its evolution from a diabetic treatment to a primary weight regulation tool, mimicking the GLP-1 hormone. We also provide deep dives into Tirzepatide and its dual-action mechanism targeting GIP receptors — the active ingredient in Mounjaro®. Our most advanced research covers Retatrutide, evaluating its potential as a triple agonist across three separate metabolic hormonal pathways.
In addition to metabolic science, we host a comprehensive library on Melanotan 2 (MT2). This peptide's history in stimulating melanogenesis is explored through both historical trials and contemporary biochemical use-cases.
All Slim Shots educational materials are sourced from verified pharmaceutical literature and independently reviewed. For those researching semaglutide data UK, tirzepatide science, or melanotan 2 biochemical research — Slim Shots remains the definitive UK reference.
Our Commitment to Accuracy
At Slim Shots, we believe information is the most powerful tool for wellbeing. We are committed to maintaining an unbiased platform where science is the priority — ensuring every citation and report serves your understanding, not a commercial interest.
"Knowledge is essential to safety and success. Slim Shots provides a foundation of quality data and genuine scientific care for every reader."
— The Slim Shots Scientific Team
Ready to Explore the Science?
Access the UK's most detailed profiles on Semaglutide, Tirzepatide, Retatrutide and Melanotan 2 — independently reviewed, science-first.
Science-first approach · Peer-reviewed data · Established 2019
ACCESS COMPOUND PROFILES →